Qt Imaging (QTI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.40, +0.84% vs the prior close of $2.38.
- Volume 26.94K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
QTI rises 0.8% to $2.40. Closed at $2.40, +0.84% vs the prior close of $2.38. Day range $2.34β$2.55, opened at $2.34.
QTI daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β QTI rises 0.8% to $2.40
- Closed at $2.40, +0.84% vs the prior close of $2.38. Day range $2.34β$2.55, opened at $2.34.
- Volume was 26.94K shares, 0.8x its 50-day average of 32.88K.
- Price is -11.7% vs its 50-day average ($2.72) and -48.4% vs its 200-day average ($4.65).
- 52-week range $2.34β$36.75; today's close sits at 0% of that range, 93.5% below the 52-week high.
Oct 15, 2026 β QTI slides 5.0% to $2.38, a 52-week low
- Closed at $2.38, -4.99% vs the prior close of $2.51. Day range $2.38β$2.54, opened at $2.42.
- Volume was 26.40K shares, 0.8x its 50-day average of 32.88K.
- Price is -12.6% vs its 50-day average ($2.72) and -49.0% vs its 200-day average ($4.67).
- 52-week range $2.38β$36.75; today's close sits at 0% of that range, 93.5% below the 52-week high.
Oct 14, 2026 β QTI rises 2.2% to $2.51
- Closed at $2.51, +2.24% vs the prior close of $2.45. Day range $2.40β$2.58, opened at $2.47.
- Volume was 27.60K shares, 0.8x its 50-day average of 33.16K.
- Price is -8.3% vs its 50-day average ($2.73) and -46.5% vs its 200-day average ($4.69).
- 52-week range $2.40β$36.75; today's close sits at 0% of that range, 93.2% below the 52-week high.
Oct 13, 2026 β QTI slides 5.8% to $2.45
- Closed at $2.45, -5.77% vs the prior close of $2.60. Day range $2.42β$2.71, opened at $2.60.
- Volume was 23.70K shares, 0.7x its 50-day average of 33.25K.
- Price is -10.4% vs its 50-day average ($2.74) and -47.9% vs its 200-day average ($4.70).
- 52-week range $2.42β$36.75; today's close sits at 0% of that range, 93.3% below the 52-week high.
Oct 12, 2026 β QTI dips 3.0% to $2.60
- Closed at $2.60, -2.99% vs the prior close of $2.68. Day range $2.56β$2.71, opened at $2.62.
- Volume was 26.00K shares, 0.8x its 50-day average of 33.10K.
- Price is -5.1% vs its 50-day average ($2.74) and -44.9% vs its 200-day average ($4.72).
- 52-week range $2.42β$36.75; today's close sits at 1% of that range, 92.9% below the 52-week high.
Oct 9, 2026 β QTI jumps 3.1% to $2.68, a 1-month high on 6.0x normal volume
- Closed at $2.68, +3.08% vs the prior close of $2.60. Day range $2.56β$2.76, opened at $2.56.
- Volume was 179.00K shares, 6.0x its 50-day average of 29.88K β unusually heavy trading.
- Price is -2.2% vs its 50-day average ($2.74) and -43.4% vs its 200-day average ($4.73).
- 52-week range $2.42β$36.75; today's close sits at 1% of that range, 92.7% below the 52-week high.
Oct 8, 2026 β QTI rises 1.2% to $2.60
- Closed at $2.60, +1.17% vs the prior close of $2.57. Day range $2.54β$2.77, opened at $2.55.
- Volume was 20.00K shares, 0.7x its 50-day average of 30.26K.
- Price is -5.1% vs its 50-day average ($2.74) and -45.3% vs its 200-day average ($4.75).
- 52-week range $2.42β$36.75; today's close sits at 1% of that range, 92.9% below the 52-week high.
Oct 7, 2026 β QTI dips 0.4% to $2.57, 3 down days in a row
- Closed at $2.57, -0.39% vs the prior close of $2.58. Day range $2.55β$2.82, opened at $2.62.
- Volume was 34.70K shares, 1.1x its 50-day average of 30.41K.
- Price is -6.3% vs its 50-day average ($2.74) and -46.1% vs its 200-day average ($4.77).
- 52-week range $2.42β$36.75; today's close sits at 0% of that range, 93.0% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 β QTI dips 1.1% to $2.58
- Closed at $2.58, -1.15% vs the prior close of $2.61. Day range $2.57β$2.77, opened at $2.68.
- Volume was 22.80K shares, 0.8x its 50-day average of 30.26K.
- Price is -6.0% vs its 50-day average ($2.74) and -46.0% vs its 200-day average ($4.78).
- 52-week range $2.42β$36.75; today's close sits at 0% of that range, 93.0% below the 52-week high.
Oct 5, 2026 β QTI dips 2.2% to $2.61
- Closed at $2.61, -2.25% vs the prior close of $2.67. Day range $2.60β$2.84, opened at $2.70.
- Volume was 33.00K shares, 1.1x its 50-day average of 29.78K.
- Price is -5.0% vs its 50-day average ($2.75) and -45.6% vs its 200-day average ($4.80).
- 52-week range $2.42β$36.75; today's close sits at 1% of that range, 92.9% below the 52-week high.
Oct 2, 2026 β QTI jumps 5.5% to $2.67
- Closed at $2.67, +5.53% vs the prior close of $2.53. Day range $2.49β$2.67, opened at $2.49.
- Volume was 17.40K shares, 0.6x its 50-day average of 29.83K β lighter than usual.
- Price is -2.9% vs its 50-day average ($2.75) and -44.6% vs its 200-day average ($4.82).
- 52-week range $2.42β$36.75; today's close sits at 1% of that range, 92.7% below the 52-week high.
QTI latest news & SEC filings
Every SEC filing by or about QTI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 31, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Aug 27, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $7.43M (prior year $3.66M) (+103.2% vs Jun 30, 2025)
- Net income: -$11.07M (prior year -$4.00M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.75 (prior year -$0.42) (loss widened vs Jun 30, 2025)
Aug 12, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 8.01 β Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 3, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 28, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
- Item 8.01 β Reported other events the company considers important.
Jul 2, 2026 Β· Form DEF 14A β Proxy statement
Proxy statement β agenda for the shareholder meeting (board elections, executive pay, votes)
Jun 22, 2026 Β· Form PRE 14A β Preliminary proxy statement
Preliminary proxy statement
Things to know before you trade QTI
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Feb 18, 2026. Based on that rhythm, the next report is likely around Nov 11, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.27% (largest 5.8%).
- Liquidity: about 32.35K shares (β$77.63K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.40 vs a range of $2.34β$36.75 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:5 on Oct 27, 2025, 1:3 on Oct 24, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Avi S Katz bought 24,107 shares on Jan 22, 2026.
- Latest filings: 8-K Aug 31, 2026; 8-K Aug 18, 2026; 10-Q Aug 12, 2026.
- Share count: 14.64M shares outstanding (Aug 12, 2026), -49.1% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Electromedical & Electrotherapeutic Apparatus.
QTI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.34 | 2.55 | 2.34 | 2.40 | 26.94K |
| Oct 15, 2026 | 2.42 | 2.54 | 2.38 | 2.38 | 26.40K |
| Oct 14, 2026 | 2.47 | 2.58 | 2.40 | 2.51 | 27.60K |
| Oct 13, 2026 | 2.60 | 2.71 | 2.42 | 2.45 | 23.70K |
| Oct 12, 2026 | 2.62 | 2.71 | 2.56 | 2.60 | 26.00K |
| Oct 9, 2026 | 2.56 | 2.76 | 2.56 | 2.68 | 179.00K |
| Oct 8, 2026 | 2.55 | 2.77 | 2.54 | 2.60 | 20.00K |
| Oct 7, 2026 | 2.62 | 2.82 | 2.55 | 2.57 | 34.70K |
| Oct 6, 2026 | 2.68 | 2.77 | 2.57 | 2.58 | 22.80K |
| Oct 5, 2026 | 2.70 | 2.84 | 2.60 | 2.61 | 33.00K |
| Oct 2, 2026 | 2.49 | 2.67 | 2.49 | 2.67 | 17.40K |
| Oct 1, 2026 | 2.59 | 2.63 | 2.52 | 2.53 | 14.00K |
| Sep 30, 2026 | 2.61 | 2.72 | 2.51 | 2.55 | 35.60K |
| Sep 29, 2026 | 2.59 | 2.65 | 2.48 | 2.58 | 28.10K |
| Sep 28, 2026 | 2.45 | 2.52 | 2.43 | 2.45 | 12.00K |
| Sep 25, 2026 | 2.51 | 2.71 | 2.42 | 2.45 | 20.70K |
| Sep 24, 2026 | 2.63 | 2.65 | 2.49 | 2.53 | 13.70K |
| Sep 23, 2026 | 2.60 | 2.78 | 2.52 | 2.58 | 26.80K |
| Sep 22, 2026 | 2.83 | 2.83 | 2.56 | 2.60 | 28.70K |
| Sep 21, 2026 | 2.64 | 2.84 | 2.56 | 2.58 | 29.80K |
About Qt Imaging
Qt Imaging (QTI) is listed on the Nasdaq and classified by the SEC under βElectromedical & Electrotherapeutic Apparatusβ. Its business address is in NOVATO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1844505.
QTI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel H Dickson | Director | Mar 24, 2026 |
| Raluca Dinu | Chief Executive Officer | Aug 31, 2026 |
| James S Greene | Director | Mar 24, 2026 |
| John C Jr Klock | Director | Mar 24, 2026 |
| Avi S Katz | Chairman | Mar 24, 2026 |
| Bryan Timm | Director | Aug 6, 2026 |
| Ross Taylor | Director | Aug 27, 2026 |
| Zeev Weiner | Director | Mar 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Raluca Dinu | Chief Executive Officer | Aug 31, 2026 |
| Jay Walter Jennings | Chief Financial Officer | Mar 24, 2026 |
| Avi S Katz | Chairman | Mar 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 22, 2026 | Avi S Katz | Buy | 24,107 | $6.43 |
| Jan 22, 2026 | Avi S Katz | Buy | 24,107 | $6.43 |
| Jan 22, 2026 | Avi S Katz | Buy | 24,107 | $6.43 |
| Jan 22, 2026 | Avi S Katz | Buy | 24,107 | $6.43 |
QTI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $18.93M | $-21.08M | -2.01 | $-8.96M |
| Dec 31, 2024 | $4.88M | $-8.98M | -2.13 | $-10.03M |
| Dec 31, 2023 | $40.35K | $-6.10M | -0.64 | $-2.65M |
| Dec 31, 2022 | β | $-2.77M | -0.60 | $-1.26M |
| Dec 31, 2021 | β | $-1.11M | -0.14 | $-1.37M |
Latest balance sheet: total assets $30.63M, total liabilities $28.38M, cash $10.92M (as of Jun 30, 2026).
QTI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $3.01 |
| May 13, 2026 | 8-K Item 2.02 (results) | $6.32 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $6.90 |
| Feb 18, 2026 | 8-K Item 2.02 (results) | $5.50 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $6.48 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $27.60 |
| May 13, 2025 | 8-K Item 2.02 (results) | $12.15 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $9.00 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $7.12 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | β |
| May 10, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on QTI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.